Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoV-Hep anticoagulation strategies in continuous hemodialysis for severe COVID-19
RBR-45kf9pRecruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jun 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in coronavirus disease 2019 (COVID-19) and acute kidney failure (AKF) comparing Control: sodium citrate with Intervention: sodium citrate + unfractionated heparin (2 arms). Started Jun 2020; status: recruiting.
02
Drugs
trisodium citrateheparin
03
Conditions
coronavirus disease 2019 (COVID-19)acute kidney failure (AKF)
Beyond the preview
Go deeper on RBR-45kf9p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-45kf9p.